Botulinum Neurotoxin: Clinical Trials

4 trials of Botulinum Neurotoxin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Early Phase 11Not yet recruiting 1
Not applicable1Completed 1

Follow Botulinum Neurotoxin: new trials by email Literature Review of Botulinum Neurotoxin trials Research Report on Botulinum Neurotoxin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device, Botulinum Neurotoxin - Interstitial Cystitis, Chronic Pain
Early Phase 1Not yet recruitingHillMed Inc.462025-09-152025-08-19
Botox for Chronic Pelvic Pain
Botulinum neurotoxin, High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device - Pelvic Floor Disorders
Phase 1RecruitingUniversity of Miami302025-02-242026-06-17
Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique
Electromyography-Needle Intramuscular Drug guidance, Botulinum toxin type A - Glabellar Frown Lines, Rhytides
Not applicableCompletedMohamed Hayder Oleish Salih152021-08-092022-08-26
Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction
Botulinum Neurotoxin, Placebo - Mood
Phase 1CompletedDeNova Research452020-07-202021-03-15

Conditions studied

Pelvic Floor Disorders (2)  ·  Chronic Pain (1)  ·  Cystitis, Interstitial (1)  ·  Facial Expression (1)  ·  Muscle Hypertonia (1)

Sponsors

DeNova Research (1)  ·  HillMed Inc. (1)  ·  Mohamed Hayder Oleish Salih (1)  ·  University of Miami (1)

Countries

United States (3)  ·  Egypt (1)

Top investigators

Mohamed H Oleish, MB BCh (1)  ·  Yingchun Zhang, PhD (1)

Results publications

PMID 26044342

NIH funding

R01DK133800 (1)